Medtronic introduces IBM Watson-powered Sugar.IQ diabetes app

“Sugar.IQ with Watson, billed as the first-of-its-kind cognitive app for people with diabetes, took center stage September 27 at the 10th Annual Health 2.0 Fall Conference. Sugar.IQ, revealed jointly by Medtronic and IBM, uses real-time continuous glucose monitoring and insulin information from Medtronic pumps and glucose sensors. It leverages IBM Watson’s cognitive computing power, combined with Medtronic’s expertise in diabetes, to find hidden patterns in diabetes data.” Read more at Healthcare IT News.



Categories: mHealth

%d bloggers like this: